中南大学 xu deng

Language : English

xu deng

Home

Journal Publications

Research Projects

Books

Patents

Teaching

Honors and Awards

Recommended Ph.D.Supervisor
Recommended MA Supervisor

MOBILE Version

Journal Publications

Current position: Home > Journal Publications

[21]Xu Deng, YingjunZhou, YuanjianLi, Yajing Wang, Guangyao Zeng, Wei Cao, Jinbao Fan, Lan Chen, Jinjin Ma.Dual-targeting Rutaecarpine-NO donor hybrids as novel anti-hypertensive agents by promoting release of CGRP[J]. Elsevier.European Journal of Medicinal Chemistry, 2019, 168 (15) : 146-153.
[22]Qin-Shi Zhao*, Ying Leng*, Li -Yan Peng, Yu Zhao, Juan He, Jing Yang, Yu Shen, Xu Deng.Discovery and Structure-Activity Relationships of ent-Kaurene Diterpenoids as Potent and Selective 11β-HSD1 Inhibitors: Potential Impact in Diabetes[J].European Journal of Medicinal Chemistry, 2013, 65: 403-414.
[23]Xu Deng & Yingjun Zhou, Yajing Wang, Wei Cao, Zhaoquan Wu, Guangyao Zeng.Identification of anti-nociceptive constituents from the pollen of Typha angustifolia L. using effect-directed fractionation[J].Natural Product Research, 2018
[24]Qin-shi Zhao*, Yan Li*, Li-Yan Peng, He, Juan, Yu Zhao, Ling-Mei Kong, Xu Deng.Exploring of drug leads from diversity-oriented Michael-acceptor library derived from natural products[J].Natural products and Bioprospecting, 2012, 2: 210-216.
[25]Qin-Shi Zhao*, Zhu-Jun Yao*, Yan Li, Li-Yan Peng, Yu Zhao, Jia Su, Xu Deng.Development of novel conformation-constrained cytotoxic derivatives of cheliensisin A by embedment of small heterocycles[J].European Journal of Medicinal Chemistry, 2011, 46: 4238-4244.
[26]Y, Mei Dong, Yin-Yin Xie, Yi Jin, Yi-Jie Liu, Run Xiao, Ying Lu, Li-Dong Shao, Xu Deng#, Bai-Xin Ye#.Vibsanin B preferentially targets HSP90？, inhibit interstitial leukocyte migration and ameliorates experimental autoimmue encephalomyelitis[J].Journal of Immunology, 2015, 194: 4489.
[27]Fe, Dong-Yun Zhang, Yong-Hui Yu, Jing-Xia Li, Xu Deng#, Liang Chen#, Guang-Xun Gao#, Jing-Jie Zhang#.Cheliesisin A inhibits EGF-induced cell transformation with stablization of p53 protein via a hydrogen peroxide/Chk1 dependent axis[J].Cancer prevention Research, 2013, 6: 949-958.
[28]Yan Li*, Qin-Shi Zhao*, Han-Dong Sun, Zhi-Li Zuo, Xu Deng#, Ling-Mei Kong#.Identification and validation of P50 as the cellular target of Eriocalyxin B[J].Oncotarget, 2014, 5: 11354.
[29]Cheng-Feng Xia*, Da-Shan Li, Ming Ding, Xiao-Gang Tong, Xu Deng, Kang-Jiang Liang.Copper-mediated radical dimerization to access 3a,3a’-bispyrrolidinoindoline: diastereoselective synthesis of (+)-WIN 64821 and (-)-ditryptophenaline[J].Organic Letters, 2015, 17: 206-209.
[30]Ho, Yan Li, Huai-Rong Luo, Bin Wu, Xiao-Nian Li, Chun-Yan Wu, Xia Liu, Xu Deng, Xing-Wei Yang.Hypercohin A, a new polycyclic polyprenylated acylphloroglucinol possessing an unusual bicyclo[5.3.1]hendecane core from Hypericum cohaerens[J].Chemical Communications, 2012, 48: 5998-6000.
[31]Cheng-Feng Xia*, Da-Shan Li, Ming Ding, Xiao-Gang Tong, Kang-Jiang Liang, Xu Deng.Biomimetic synthesis of chaetominine epimers via copper-catalyzed radical cyclization[J].Tetrahedron, 2015, 71: 3699-3704.

total31 2/2

first previousnextlast Page